MDT

84.06

+0.04%↑

VEEV

226.15

-0.01%↓

A

105.7

-0.57%↓

WBA

11

+0.09%↑

CHE

551.68

-1.39%↓

MDT

84.06

+0.04%↑

VEEV

226.15

-0.01%↓

A

105.7

-0.57%↓

WBA

11

+0.09%↑

CHE

551.68

-1.39%↓

MDT

84.06

+0.04%↑

VEEV

226.15

-0.01%↓

A

105.7

-0.57%↓

WBA

11

+0.09%↑

CHE

551.68

-1.39%↓

MDT

84.06

+0.04%↑

VEEV

226.15

-0.01%↓

A

105.7

-0.57%↓

WBA

11

+0.09%↑

CHE

551.68

-1.39%↓

MDT

84.06

+0.04%↑

VEEV

226.15

-0.01%↓

A

105.7

-0.57%↓

WBA

11

+0.09%↑

CHE

551.68

-1.39%↓

Search

Abbott Laboratories

Deschisă

SectorSănătate

128.37 -1.17

Rezumat

Modificarea prețului

24h

Curent

Minim

127.11

Maxim

130.1

Indicatori cheie

By Trading Economics

Venit

7.6B

9.2B

Vânzări

339M

11B

P/E

Medie Sector

17.001

57.333

EPS

1.09

Randament dividend

1.8

Marjă de profit

84.099

Angajați

114,000

EBITDA

82M

3B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+11.42% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.80%

2.63%

Data viitoare de dividende

15 mai 2025

Următoarea dată ex-dividende

14 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

3B

225B

Deschiderea anterioară

129.54

Închiderea anterioară

128.37

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

Abbott Laboratories Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 apr. 2025, 16:21 UTC

Câștiguri

Abbott Labs Bracing for Tariffs as Profits Rise -- Update

16 apr. 2025, 12:14 UTC

Câștiguri

Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices

22 ian. 2025, 19:03 UTC

Câștiguri

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 ian. 2025, 18:20 UTC

Câștiguri

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 ian. 2025, 12:45 UTC

Câștiguri

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

16 apr. 2025, 15:09 UTC

Market Talk

Abbott Says Tariffs Killed Chances of an Outlook Raise -- Market Talk

16 apr. 2025, 14:17 UTC

Câștiguri

Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations -- Barrons.com

16 apr. 2025, 11:34 UTC

Câștiguri

Abbott Labs 1Q Gross Margin of 52.8 % of Sales; Adj Gross Margin of 57.1 % >ABT

16 apr. 2025, 11:33 UTC

Câștiguri

Abbott Labs Projects FY25 Adj Operating Margin to Be 23.5% to 24.0% of Sales >ABT

16 apr. 2025, 11:32 UTC

Câștiguri

Abbott Labs Backs FY25 Adj EPS $5.05-Adj EPS $5.25 >ABT

16 apr. 2025, 11:32 UTC

Câștiguri

Abbott Labs Sees 2Q Adj EPS $1.23-Adj EPS $1.27 >ABT

16 apr. 2025, 11:31 UTC

Câștiguri

Abbott Labs Projects FY25 Organic Sales Growth of 7.5% to 8.5% >ABT

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Reaffirms Full-Yr Guidance

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Labs 1Q Organic Sales Growth Up 6.9% >ABT

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Labs 1Q Sales $10.36B >ABT

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Labs 1Q Net $1.33B >ABT

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Labs 1Q EPS 76c >ABT

16 apr. 2025, 11:30 UTC

Câștiguri

Abbott Labs 1Q Adj EPS $1.09 >ABT

16 apr. 2025, 09:57 UTC

Acțiuni populare

Stocks to Watch: Nvidia, AMD, Heineken, ASML -- WSJ

1 feb. 2025, 18:14 UTC

Top știri

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 ian. 2025, 16:40 UTC

Top știri
Câștiguri

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 ian. 2025, 15:20 UTC

Câștiguri

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 ian. 2025, 15:08 UTC

Câștiguri

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ian. 2025, 13:51 UTC

Câștiguri

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 ian. 2025, 13:39 UTC

Top știri
Câștiguri

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ian. 2025, 12:02 UTC

Câștiguri

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 ian. 2025, 12:01 UTC

Câștiguri

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 ian. 2025, 12:01 UTC

Câștiguri

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q Net $9.23B >ABT

Comparație

Modificare preț

Abbott Laboratories Așteptări

Obiectiv de preț

By TipRanks

11.42% sus

Prognoză pe 12 luni

Medie 144.15 USD  11.42%

Maxim 159 USD

Minim 127 USD

În baza a 21 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAbbott Laboratories - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

21 ratings

18

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

128.52 / 129.7Suport & Rezistență

Termen scurt

Weak Bullish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.